ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0415

Characteristics of Arthritis in Adult IgA Vasculitis

Alojzija Hocevar1, Vesna Jurcic2, Matija Tomsic1 and Ziga Rotar1, 1University Medical Center Ljubljana, LJUBLJANA, Slovenia, 2Institute of Pathology, Medical Faculty, University of Ljubljana, LJUBLJANA, Slovenia

Meeting: ACR Convergence 2020

Keywords: Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Arthritis is one of the main clinical features in IgA vasculitis (IgAV). In children, joint involvement represents the second most common manifestation with the prevalence of ≈75%, and predilection for the knees and ankles. The aim of our study was to describe the characteristics of arthritis in adult IgAV.

Methods: We analysed medical records of histologically proven adult IgAV cases, diagnosed between January 2010 and May 2020 at our secondary/tertiary rheumatology centre. The frequency, temporal occurrence and the localization of arthritis was recorded. Additionally, we explored potential differences in other clinical features of acute IgAV between patients with and without arthritis.

Results: During the 125-month observation period we identified 313 new IgAV cases (60.7 % males, median (IQR) age 64.6 (45.6; 77.1) years). Arthritis developed in 48 (15.3%) patients and was the first IgAV manifestation in 16 (5.1%) patients. Arthritis was mono-, oligo- and poly- articular (involving up to 15 joints) in 13 (4.2%), 25 (8%) and 10 (3.2%) patients, respectively. Arthritis was most common in wrists and ankles (each in 18 (37.5%) patients); metacarpophalangeal joints and knees (each in 11 (22.9%)); proximal interphalangeal joints (9 (18.8%)); elbows (8 (16.7%)) and metatarsophalangeal joints (4 (8.3%)). Table 1 shows clinical differences between IgAV patients with and without arthritis. Patients with arthritis were significantly younger, more commonly had gastrointestinal tract involvement and less frequently elevated serum IgA. Arthritis remitted in all with immunomodulatory treatment (given predominantly for necrotic skin purpura or visceral involvement). Follow up (FU) data accessible for 40/48 (83.3%) patients with arthritis showed that IgAV relapsed in 10 (25%) patients during a median (IQR) 24.6 (11.2; 41.8) month FU. Relapses were limited to skin and/or kidneys, there were no relapses of arthritis.

Conclusion: Arthritis more commonly affected younger adults with IgAV, was frequently oligoarticular, involved large and small joints of both upper and lower extremities and unlike skin lesions or renal involvement was not prone to chronic course and recurrence.

Table 1. Clinical characteristics of IgA vasculitis patients with and without arthritis


Disclosure: A. Hocevar, None; V. Jurcic, None; M. Tomsic, None; Z. Rotar, None.

To cite this abstract in AMA style:

Hocevar A, Jurcic V, Tomsic M, Rotar Z. Characteristics of Arthritis in Adult IgA Vasculitis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/characteristics-of-arthritis-in-adult-iga-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characteristics-of-arthritis-in-adult-iga-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology